Arteris, Inc. AIP · NASDAQ
$18.10 -2.84% (-$0.53)
Summary
36 / 100 · Bulios Score
What speaks for it
- It holds more cash than debt: $93.3M against $8.69M.
- Analysts expect revenue to grow by 37% this fiscal year.
What to watch
- The company made a loss over the last 12 months.
- The share price is above the Bulios Fair Price.
- It passes only 3 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 17% a year over 5 years. Over the last 3 years it grew by 12% a year. For the next fiscal year analysts expect revenue to grow by 37%.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $39.5M.
Profitability in detailIs it financially healthy?
YesRepaying all its debt would take 1.3 years of free cash flow. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 6
- Hold 1
- Sell 0
Today's price within the analysts' price targets
The average target of $39.6 is 119% above today's price. 86% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- License and Maintenance 90%
- Royalty 9.3%
- Service, Other 0.2%
By region
- Asia Pacific 25%
- Americas 22%
- UNITED STATES 21%
- CHINA 13%
- KOREA, REPUBLIC OF 6.4%
- Other 13%
License and Maintenance brings in 90% of revenue. Royalty grew fastest, by 26% a year.
Segments in detail